Home / GLP-1 appeals / Mounjaro / Anthem
Mounjaro denial · Anthem
Anthem denied your Mounjaro. Here is how to appeal it.
Most Anthem GLP-1 denials are winnable, if your appeal speaks to Anthem's own policy and lands before the deadline. We draft it for free, grounded in Anthem's actual coverage rules with every citation verified. You review, sign, and file it.
Free to draft. Every citation checked against Anthem's policy before you file.
Your deadline
Often 180 days
For Anthem's first internal appeal on commercial and ACA plans. State rules can differ. Your denial notice controls, check it.
Most common reason
Off-label for weight loss
If the claim reads as weight-loss use, Anthem may deny because Mounjaro's on-label use is type 2 diabetes.
What wins
Name the guideline
Request the exact MCG guideline Anthem applied, then meet it point by point with your records.
Why Anthem denies Mounjaro
Mounjaro (tirzepatide) is FDA-approved to improve blood sugar in adults with type 2 diabetes. Anthem covers it under the pharmacy benefit on many plans, behind prior authorization and often step therapy. Denials usually come down to a handful of patterns:
- Denied as off-label for weight loss. Mounjaro's on-label use is type 2 diabetes. If the claim reads as a weight-management request, Anthem may deny it. The fix is to make the type 2 diabetes indication explicit in the record, so the claim is reviewed against the indication it actually qualifies under.
- Step therapy or fail-first. Many Anthem plans require a documented trial of metformin or other preferred agents before Mounjaro. If your records do not show that trial clearly, the claim is denied even when the trial happened.
- Formulary tier or non-preferred status. Mounjaro may sit on a non-preferred tier on your plan's formulary, which can trigger a denial or require you to clear added requirements before it is covered.
- No prior authorization, or MCG criteria not met. Prior authorization denials are Anthem's single leading category, and Anthem applies MCG Care Guidelines for medical-necessity decisions. A missing authorization, or records that do not show the specific facts the guideline requires, leads to a denial.
How to win the appeal with Anthem
The pattern that works against Anthem is to make the guideline visible: get them to name the rule they applied, then meet it on the record.
The move: request the specific MCG Care Guideline Anthem applied to your case, then answer each element of it in order with the page of your record that proves it. Prior authorization and MCG-based medical necessity are Anthem's leading denial categories, so meeting the named guideline point by point is where appeals are won. If you are a fully insured California member, you have an extra lever: you can use California's Independent Medical Review (IMR) through the DMHC, and California members can file directly with the DMHC for an IMR rather than waiting out Anthem's internal appeals. Also check your denial letter's appeal-rights language, in May 2025 California's DMHC fined Anthem $750,000 specifically for sending denial letters with wrong information about appeal rights, so a letter that misstates your rights is a problem for the insurer.
- Make the type 2 diabetes indication explicit, so the claim is reviewed against Mounjaro's on-label use rather than read as a weight-loss request.
- Request the specific MCG Care Guideline Anthem used, then respond to each element directly with the record that meets it.
- Attach the documentation the policy asks for: your type 2 diabetes diagnosis, prior diabetes therapies such as metformin, and relevant labs like A1c, dated.
- File within the window. On Anthem commercial and ACA plans the first internal appeal is often due within 180 days of the denial notice. If that is denied, you have the right to a further internal level where offered and then an independent external review.
- Use your federal appeal rights. Under the ACA you are entitled to a full internal appeal and then an external review by an independent reviewer. We map your appeal to those steps so nothing lapses.
Sources include Anthem's published coverage policy for GLP-1 agents and type 2 diabetes therapies and the Mounjaro prescribing information. We cite the specific policy that applies to your plan when we build your appeal.
The magic is visible
Your appeal, built from Anthem's own rules. Every citation checked.
We draft from the sources below, then verify each one before you file. On our held-out testing: 0 invented citations, versus about 1 in 4 for raw AI.
- Anthem's coverage policyThe specific Anthem medical policy or clinical guideline for GLP-1 agents and type 2 diabetes therapies that applies to your planVerified
- FDA labelTirzepatide (Mounjaro) prescribing information, indications and dosingVerified
- Your recordsYour type 2 diabetes diagnosis, prior diabetes therapies, and relevant labs (such as A1c), cited back accuratelyVerified
Let's check your Anthem denial, free.
Answer a few questions for an honest read on your odds, then your verified draft. No account, no cost.
Check my denial, freeAnthem + Mounjaro: common questions
How long do I have to appeal?
Do I need my doctor to appeal?
Why was my Mounjaro denied as off-label or not medically necessary?
Is this really free?
Other Mounjaro appeals: UnitedHealthcare · Cigna · Aetna · All Mounjaro denials